Release of antifungal agent Turbine tablets

 

 

 

 

The sale of Turbine tablets, an antifungal agent belonging to the Allyamine family, began on December 1.

Turbine tablets inhibit squalene epoxidase, which is a step earlier than other azole antifungal agents, and squalene accumulates within cells, which has a fungicidal effect on fungi. In addition, due to the lack of ergosterol, it also exhibits antifungal action and has excellent effects.

 

 

 

Terbin Tab.

● Ingredient content Terbinafine Hydrochloride 140.625mg/1Tab

(Terbinafine 125mg)

● Classification number 629/antifungal agents

● Insurance code A17603711

● Efficacy and effect

Adult 1. Dermatophytosis such as: tinea pedis, tinea capitis, tinea corporis

2. Onychomycosis

Pediatric tinea capitis

● Dosage and dosage


Adults: Administer 125 mg twice a day or 250 mg once a day.

1. Dermatophytosis

- Tinea pedis (interphalangeal type, plantar type/moccasin type) 2-6 weeks

- Tinea capitis (jock itch) 2-4 weeks

- Tinea corporis 4 weeks

2. Onychomycosis

Typically administered for 6 weeks to 3 months


Children over 2 years of age

Weight less than 20 kg - once a day, administer 62.5 mg once

Body weight 20-40kg - once a day, administer 125mg once a time

Weight exceeding 40kg - Administer 250mg once a day

- Tinea capitis 4 weeks

Tinea capitis mainly occurs in children.

To prevent recurrence of infection, treatment must be performed regularly and for an appropriate period of time.


● Standard drug price 649 won

● Packaging unit 100T, 300T